Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ischemic stroke: new therapeutic possibilities].

W Lang1, H Domanovits, H Görzer

  • 1Universitätsklinik für Neurologie, Wien.

Acta Medica Austriaca
|September 9, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arterial stiffness in acute COVID-19 and potential associations with clinical outcome.

Journal of internal medicine·2021
Same author

Hemodynamic effects of Vernakalant in cardio-surgical ICU-patients treated for recent-onset postoperative atrial fibrillation.

Scientific reports·2020
Same author

The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran.

Journal of thrombosis and haemostasis : JTH·2017
Same author

[Acute aortic syndrome].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2014
Same author

Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management.

Wiener klinische Wochenschrift·2012
Same author

Reduced hands-off-time and time to first shock in CPR according to the ERC Guidelines 2005.

Resuscitation·2008

New stroke therapies include thrombolysis, fibrinogen reduction, and aspirin. Stroke units improve acute care, while new anti-platelet drugs and carotid surgery criteria advance secondary prevention.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Pharmacology

Context:

  • Acute ischemic stroke management has evolved with recent randomized placebo-controlled studies.
  • Therapeutic strategies now encompass various interventions for stroke patients.

Purpose:

  • To review recent advancements in acute ischemic stroke therapy and secondary stroke prevention.
  • To highlight the impact of new drugs and treatment protocols.

Summary:

  • Recent studies introduce thrombolysis (intraarterial/intravenous), fibrinogen level reduction, and aspirin for acute ischemic stroke.
  • High-dose heparin efficacy is limited to specific patient groups.
  • Stroke units demonstrate effectiveness in acute stroke care.
  • Secondary stroke prevention is enhanced by new anti-platelet agents and refined carotid surgery criteria.

Related Experiment Videos

Impact:

  • These advances offer improved treatment options for acute ischemic stroke.
  • Enhanced secondary prevention strategies aim to reduce stroke recurrence.
  • The findings guide clinical practice and future research in cerebrovascular disease.